Correction To: Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial

被引：0

作者：

Shukui Qin

Jin Li

Haijun Zhong

Chuan Jin

Lili Chen

Xianglin Yuan

Qingxia Fan

Kehe Chen

Peiguo Cao

Jianjun Xiao

Da Jiang

Tao Zhang

Hongyu Zhang

Xicheng Wang

Wei Wang

Lin Han

Qingyu Wang

Jun Zhu

机构：

[1] Eastern Theater General Hospital of PLA China,Department of Oncology, Qinhuai Medical Area

[2] Tongji University Shanghai East Hospital,Department of Oncology

[3] Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital),Department of Abdominal Oncology

[4] Affiliated Cancer Hospital and Institute of Guangzhou Medical University,Department of Oncology

[5] Taizhou First People’s Hospital,Department of Hematology and Oncology

[6] Tongji Hospital,Department of Oncology

[7] Huazhong University of Science and Technology,Department of Oncology

[8] The First Affiliated Hospital of Zhengzhou University,Department of Oncology

[9] The People’s Hospital of Guangxi Zhuang Autonomous Region,Department of Oncology

[10] The Third Xiangya Hospital of Central South University,Chemotherapeutic Department

[11] Zhongshan City People’s Hospital,Department of Oncology

[12] The Fourth Hospital of Hebei Medical University,Department of Oncology

[13] The First Affiliated Hospital of Chongqing Medical University,Cancer Center

[14] The Fifth Affiliated Hospital Sun Yat-sen University,Department of Oncology

[15] The First Affiliated Hospital of Guangdong Pharmaceutical University,Department of Gastrointestinal Oncology

[16] The First People’s Hospital of Foshan,undefined

[17] Shanghai Henlius Biotech,undefined

[18] Inc.,undefined

来源：

British Journal of Cancer | 2022年 / 127卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2249 / 2249

共 50 条

[21] A phase 1 study of serplulimab, a novel humanized monoclonal anti-PD-1 antibody, in patients with advanced solid tumors.
Ho, Ching-Liang
Chao, Tsu-Yi
Chang, Chia Lun
Lin, Hsuan-Yu
Yang, Futang
Wang, Qingyu
Zhu, Jun
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[22] Anti-PD-1 antibody HX008 combined with oxaliplatin plus capecitabine for advanced gastric or esophagogastric junction cancer: a multicenter, single-arm, open-label, phase Ib trial
Xu, Jianming
Xu, Nong
Bai, Yuxian
Liu, Rongrui
Mao, Chenyu
Sui, Hong
Wang, Xiaofei
Jiang, Qian
Dou, Yiwei
ONCOIMMUNOLOGY, 2021, 10 (01):
[23] Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
Gao, Xiangyu
Xu, Nong
Li, Ziyu
Shen, Lin
Ji, Ke
Zheng, Zhong
Liu, Dan
Lou, Hanmei
Bai, Li
Liu, Tianshu
Li, Yunxia
Li, Yuzhi
Fan, Qingxia
Feng, Mei
Zhong, Haijun
Huang, Yi
Lou, Ge
Wang, Jing
Lin, Xiaoyan
Chen, Ye
An, Ruifang
Li, Changzheng
Zhou, Qi
Huang, Xin
Guo, Zengqing
Wang, Shubin
Li, Guiling
Fei, Junwei
Zhu, Lijing
Zhu, Hong
Li, Xiumin
Li, Fenghu
Liao, Sihai
Min, Qinghua
Tang, Lei
Shan, Fei
Gong, Jifang
Gao, Yunong
Zhou, Jun
Lu, Zhihao
Li, Xiaofan
Li, Jianjie
Ren, Hui
Liu, Xiaohong
Yang, Hongxia
Li, Wenting
Song, Weifeng
Wang, Zhongmin Maxwell
Li, Baiyong
Xia, Michelle
LANCET ONCOLOGY, 2023, 24 (10): : 1134 - 1146
[24] Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial
Davis, Kara L.
Fox, Elizabeth
Merchant, Melinda S.
Reid, Joel M.
Kudgus, Rachel A.
Liu, Xiaowei
Minard, Charles G.
Voss, Stephan
Berg, Stacey L.
Weigel, Brenda J.
Mackall, Crystal L.
LANCET ONCOLOGY, 2020, 21 (04): : 541 - 550
[25] Neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in patients with potentially resectable NSCLC: An open-label, single-arm, phase II trial
Zhu, X.
Sun, L.
Song, N.
Sun, F.
Yang, J.
Duan, L.
Zhao, D.
He, W.
Luo, J.
Zhang, H.
Wu, C.
Zhu, Y.
Zhang, P.
Jiang, G.
ANNALS OF ONCOLOGY, 2021, 32 : S942 - S942
[26] Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial
Loeb, David M.
Lee, Ji Won
Morgenstern, Daniel A.
Samson, Yvan
Uyttebroeck, Anne
Lyu, Chuhl Joo
Van Damme, An
Nysom, Karsten
Macy, Margaret E.
Zorzi, Alexandra P.
Xiong, Julia
Pollert, Petra
Joerg, Ingrid
Vugmeyster, Yulia
Ruisi, Mary
Kang, Hyoung Jin
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (10) : 2485 - 2495
[27] Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial
David M. Loeb
Ji Won Lee
Daniel A. Morgenstern
Yvan Samson
Anne Uyttebroeck
Chuhl Joo Lyu
An Van Damme
Karsten Nysom
Margaret E. Macy
Alexandra P. Zorzi
Julia Xiong
Petra Pollert
Ingrid Joerg
Yulia Vugmeyster
Mary Ruisi
Hyoung Jin Kang
Cancer Immunology, Immunotherapy, 2022, 71 : 2485 - 2495
[28] Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer
Wirth, Lori J.
Brose, Marcia S.
Sherman, Eric J.
Licitra, Lisa
Schlumberger, Martin
Sherman, Steven, I
Bible, Keith C.
Robinson, Bruce
Rodien, Patrice
Godbert, Yann
De La Fouchardiere, Christelle
Newbold, Kate
Nutting, Christopher
Misir, Soamnauth
Xie, Ran
Almonte, Ana
Ye, Weifei
Cabanillas, Maria E.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (21) : 2359 - +
[29] Open-label, phase I, dose escalation/expansion trial of the anti-SIRPa monoclonal antibody BI 770371 in patients with advanced solid tumours, alone or in combination with the anti-PD-1 monoclonal antibody ezabenlimab
Gutierrez, M.
Jamal, R.
Yamamoto, N.
Doi, T.
Elgadi, M.
Ferrada, J. L.
Wojciekowski, S. M.
Patel, M. R.
ANNALS OF ONCOLOGY, 2023, 34 : S485 - S485
[30] Anti-PD-1 Antibody (Sintilimab) Plus Decitabine As First Line Treatment for Patients with Higher-Risk Myelodysplastic Syndrome (MDS): Primary Results from a Single-Arm,Open-Label,Phase II Study
Wang, Jing
Li, Siqi
Jiang, Hao
Chang, Ying-Jun
Zhao, Xiao-Su
Jia, Jinsong
Zhu, Xiaolu
Gong, Lizhong
Liu, Xiaohong
Yu, Wen-Jing
Huang, Xiaojun
BLOOD, 2023, 142

← 1 2 3 4 5 →